Who Knows Best (Interests)? The Case of Charlie Gard

Area of Science:

• Medical Ethics
• Pediatric Neurology
• Legal Medicine

Background:

• Charlie Gard's diagnosis with a rare mitochondrial disease led to a search for unproven nucleoside therapy.
• Extensive public fundraising (£1.3 million) supported experimental treatment options.
• Legal battles ensued over whether the proposed therapy aligned with Charlie Gard's best interests.

Purpose of the Study:

• To critically analyze the legal principles governing unproven treatments.
• To examine the application of the "best interests" test in pediatric cases.
• To compare legal approaches to unproven treatments for children versus adults lacking capacity.

Main Methods:

• Case study analysis of Charlie Gard's situation.
• Critical review of legal judgments and appeals.
• Comparative analysis of legal principles in different contexts (hospital vs. court).

Main Results:

• The court ultimately determined that the unproven therapy was not in Charlie Gard's best interests.
• The decision was upheld through multiple levels of appeal.
• Conflicting guidance and differing approaches to "best interests" were identified.

Conclusions:

• The case highlights the complexities of applying the "best interests" test for unproven therapies in pediatric cases.
• There are notable differences in legal approaches to unproven treatments for children compared to adults lacking capacity.
• Further clarification of legal and ethical guidelines is needed for such complex medical-ethical dilemmas.